182 related articles for article (PubMed ID: 28916401)
1. CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
Ito T; Hanafusa N
Transfus Apher Sci; 2017 Oct; 56(5):703-707. PubMed ID: 28916401
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
[TBL] [Abstract][Full Text] [Related]
3. Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites.
Ito T; Hanafusa N; Fukui M; Yamamoto H; Watanabe Y; Noiri E; Iwase S; Miyagawa K; Fujita T; Nangaku M
Ther Apher Dial; 2014 Feb; 18(1):87-92. PubMed ID: 24499089
[TBL] [Abstract][Full Text] [Related]
4. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
6. Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
Yorioka N; Namisaki T; Shibamoto A; Suzuki J; Kubo T; Iwai S; Tomooka F; Tanaka M; Takeda S; Fujimoto Y; Enomoto M; Muarata K; Inoue T; Tsuji Y; Fujinaga Y; Nishimura N; Kitagawa K; Takaya H; Kaji K; Kawaratani H; Akahane T; Mitoro A; Yamazaki M; Yoshiji H
In Vivo; 2023; 37(3):1226-1235. PubMed ID: 37103093
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
8. Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.
Takahashi H; Sakai R; Fujita A; Kuwabara H; Hattori Y; Matsuura S; Ohshima R; Hagihara M; Tomita N; Ishigatsubo Y; Fujisawa S
Artif Organs; 2013 Oct; 37(10):932-6. PubMed ID: 23692354
[TBL] [Abstract][Full Text] [Related]
9. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
10. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
Iwasa M; Ishihara T; Kato M; Isoai A; Kobayashi R; Torii N; Soneda N; Takei Y
Intern Med; 2019 Nov; 58(21):3069-3075. PubMed ID: 31292400
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
12. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
[TBL] [Abstract][Full Text] [Related]
14. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.
Hanafusa N; Isoai A; Ishihara T; Inoue T; Ishitani K; Utsugisawa T; Yamaka T; Ito T; Sugiyama H; Arakawa A; Yamada Y; Itano Y; Onodera H; Kobayashi R; Torii N; Numata T; Kashiwabara T; Matsuno Y; Kato M
PLoS One; 2017; 12(5):e0177303. PubMed ID: 28510606
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis.
Chen H; Ishihara M; Horita N; Tanzawa S; Kazahari H; Ochiai R; Sakamoto T; Honda T; Ichikawa Y; Watanabe K; Seki N
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638357
[TBL] [Abstract][Full Text] [Related]
18. Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.
Yamada Y; Inui K; Hara Y; Fuji K; Sonoda K; Hashimoto K; Kamijo Y
Sci Rep; 2019 Jul; 9(1):10195. PubMed ID: 31308465
[TBL] [Abstract][Full Text] [Related]
19. Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.
Matsumoto N; Ogawa M; Kanda T; Matsuoka S; Moriyama M; Matsusaki K
J Med Ultrason (2001); 2021 Jul; 48(3):315-322. PubMed ID: 33835337
[TBL] [Abstract][Full Text] [Related]
20. Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hanai T; Kawaratani H; Nagano J; Suii H; Sakamaki A; Arase Y; Nakanishi H; Kogiso T; Okubo T; Miwa T; Shimizu S; Hige S; Atsukawa M; Shimizu M; Kurosaki M; Terai S; Kagawa T; Tokushige K; Yoshiji H
Hepatol Res; 2023 Mar; 53(3):238-246. PubMed ID: 36433862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
